Beryl Drugs

Beryl Drugs Limited is an Indian public company founded in 1993 and is principally involved in manufacturing bulk pharmaceutical drugs. The company's vision document provides a clear direction for its policies and procedures, ensuring the business remains sustainable for the long term. It operates with a strong emphasis on values like employee empowerment, safety, transparency in decision-making, and fair, ethical business dealings. Its business operations are concentrated exclusively in the pharmaceutical manufacturing sector, allowing for deep focus and expertise in this area. A key component of its strategy is the commitment to consistently deliver quality products to the market at competitive prices. Demonstrating its business activity, the company recorded a total turnover of ₹26.73 crores for the financial year 2023-2024.;